常染色体显性多囊肾病患者的症状前颅内动脉瘤筛查
该研究回顾性分析了1989至2017年间Mayo Clinic的3010例常染色体显性多囊肾病(ADPKD)患者,其中812例接受了症状前磁共振血管造影筛查。结果显示9%的患者检出颅内动脉瘤,有蛛网膜下腔出血家族史、高血压或吸烟者更常见;筛查未检出动脉瘤的患者中动脉瘤破裂率为0.04/100人年。
要点
- ADPKD患者症状前筛查颅内动脉瘤检出率为9%。
- 蛛网膜下腔出血家族史、高血压和吸烟与动脉瘤检出相关。
- 筛查未检出动脉瘤者破裂率低,为0.04/100人年。
核心结论
- 症状前筛查在9%的ADPKD患者中检出颅内动脉瘤,有蛛网膜下腔出血家族史、高血压或吸烟者更常见。
- 筛查检出动脉瘤的患者无破裂,未检出动脉瘤的患者中有2例破裂,队列总体破裂率约为一般人群的五倍。
研究设计与样本
- 回顾性队列研究,纳入1989至2017年Mayo Clinic评估的3010例ADPKD患者中接受症状前磁共振血管造影筛查者。
主要发现
- 大多数动脉瘤较小(中位直径4 mm;范围2-12 mm),85%位于前循环。
- 影像随访共469患者年,5例检出新发颅内动脉瘤,8个动脉瘤增大(中位增大2 mm;范围1-3 mm)。
- 临床随访共668患者年,7例接受预防性夹闭或弹簧圈栓塞,无动脉瘤破裂。
临床怎么用
- 对ADPKD患者进行症状前颅内动脉瘤筛查可检出约9%的动脉瘤,尤其是有蛛网膜下腔出血家族史、高血压或吸烟者。
- 筛查未检出动脉瘤的患者动脉瘤破裂风险低,但仍需关注总体破裂率高于一般人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Intracranial aneurysm rupture is the most devastating complication of autosomal dominant polycystic kidney disease. Whether selective or widespread intracranial aneurysm screening is indicated remains controversial. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: Records of 3010 patients with autosomal dominant polycystic kidney disease evaluated at the Mayo Clinic between 1989 and 2017 were reviewed. Those who had presymptomatic magnetic resonance angiography screening were included. RESULTS: Ninety-four intracranial aneurysms were diagnosed in 75 of 812 (9%) patients who underwent magnetic resonance angiography screening. Sex, age, race, and genotype were similar in the groups with and without aneurysms; hypertension and history of smoking were more frequent in the aneurysm group. Twenty-nine percent of patients with aneurysms compared with 11% of those without aneurysms had a family history of subarachnoid hemorrhage (P<0.001). Most aneurysms were small (median diameter =4 mm; range, 2-12 mm); 85% were in the anterior circulation. During a total imaging follow-up of 469 patient-years, de novo intracranial aneurysms were detected in five patients; eight intracranial aneurysms grew (median =2 mm; range, 1-3 mm). During a total clinical follow-up of 668 patient-years, seven patients had preemptive clipping or coil embolization; no intracranial aneurysms ruptured. During a total clinical follow-up of 4783 patient-years in 737 patients with no intracranial aneurysm detected on the first magnetic resonance angiography screening, two patients had an intracranial aneurysm rupture (0.04 per 100 person-years; 95% confidence interval, 0 to 0.10). The rate of intracranial aneurysm rupture in large clinical trials of autosomal dominant polycystic kidney disease was 0.04 per 100 patient-years (95% confidence interval, 0.01 to 0.06). CONCLUSIONS: Intracranial aneurysms were detected by presymptomatic screening in 9% of patients with autosomal dominant polycystic kidney disease, more frequently in those with familial history of subarachnoid hemorrhage, hypertension, or smoking. None of the patients with and two of the patients without aneurysm detection on screening suffered aneurysmal ruptures. The overall rupture rate in our autosomal dominant polycystic kidney disease cohort was approximately five times higher than that in the general population.
引用
- Sanchis IM, Shukoor S, Irazabal MV, et al. Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2019. PMID: 31362991. doi:10.2215/CJN.14691218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。